Hamdouchi, Chafiq <br/><br/>
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus.  [electronic resource] 

 -  Journal of medicinal chemistry  02 2018 
 - 934-945 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1520-4804 
<br/><br/><label>Standard No.: </label>10.1021/acs.jmedchem.7b01411  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dogs<br/>Drug Discovery<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Male<br/>Pyridines--administration & dosage<br/>Rats<br/>Receptors, G-Protein-Coupled--agonists<br/>Structure-Activity Relationship<br/>Triazoles--administration & dosage